Inactive Instrument

Luminex Corporation

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Luminex Corporation Seeks Acquisitions

January 11, 2018 at 05:00 am

Luminex Corporation (NasdaqGS:LMNX) is looking for acquisitions.

Latest news about Luminex Corporation

Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	27/02/23	CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call	13/02/23
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	12/02/23	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	15/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	15/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	15/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	15/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	15/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	15/07/21	CI
Luminex Corporation Announces Executive Changes	14/07/21	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	14/07/21	CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	13/07/21	CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading	13/07/21	MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600	13/07/21	MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index	13/07/21	CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15	12/07/21	MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin	09/07/21	MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17	20/05/21	MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021	20/05/21	CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	05/05/21	CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	13/04/21	MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	13/04/21	MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate	12/04/21	MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon	12/04/21	MT
Sector Update: Health Care	12/04/21	MT

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	187B
INTUITIVE SURGICAL, INC.	+26.34%	155B
BOSTON SCIENTIFIC CORPORATION	+33.90%	115B
SIEMENS HEALTHINEERS AG	+2.17%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	45.25B
AGILENT TECHNOLOGIES, INC.	-3.98%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.72B

Other Advanced Medical Equipment & Technology